PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31038675 ↗2019Reported benefit

Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome.

MouseRadiationMaleIntramuscular injectionProphylactic, 48 h to 12 h before irradiation with maximum effect at 24 h befor…

Model: Total body irradiation producing haematopoietic acute radiation syndrome; several total body irradiation doses used to derive a dose reduction factor

A single prophylactic intramuscular injection given 48 h to 12 h before irradiation improved survival after lethal total body irradiation, with the best effect at 24 h, and the benefit was oestrogen receptor dependent.

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.